Guidelines for monitoring heparin by the activated clotting time when aprotinin is used during cardiopulmonary bypass
- 1 July 1992
- journal article
- other
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 104 (1) , 211-212
- https://doi.org/10.1016/s0022-5223(19)34860-3
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Increased anticoagulation during cardiopulmonary bypass by aprotininThe Journal of Thoracic and Cardiovascular Surgery, 1990
- Inhibition by aprotinin of tPA-mediated fibrinolysis during orthotopic liver transplantationThe Lancet, 1990
- EFFECT OF APROTININ ON NEED FOR BLOOD TRANSFUSION AFTER REPEAT OPEN-HEART SURGERYThe Lancet, 1987
- Activated Coagulation Time Method for Control of Heparin is Reliable during Cardiopulmonary BypassAnesthesiology, 1984